Lu­minopia scores $16M for vir­tu­al re­al­i­ty-based lazy eye treat­ment

A Cam­bridge, MA-based biotech has se­cured an­oth­er $16 mil­lion to ex­pand its dig­i­tal ther­a­peu­tic for lazy eye.

Lu­minopia an­nounced a Se­ries A round on Tues­day …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER